Science Magazine· @ScienceMagazine · X·· 12 天前AI 评分18
AI 导读
一种新型双特异性抗体同时靶向CCR8以清除调节性T细胞,并靶向CD3以激活更广泛的抗肿瘤T细胞大军。该抗体在小鼠中对抗多种肿瘤类型并增强免疫疗法效果,同时在大型动物中表现安全。@ScienceTM https://scim.ag/4dZ2uL2
正文
A new bispecific antibody targets both CCR8 to deplete regulatory T cells and CD3 to revitalize the broader anti-tumor T cell armada. It combated multiple tumor types and potentiated immunotherapy in mice while being safe in large animals. @ScienceTM https://scim.ag/4dZ2uL2
来源:Science Magazine · x.com